BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:13 PM
 | 
Sep 10, 2012
 |  BC Extra  |  Company News

FDA issues complete response for Lymphoseek

Navidea Biopharmaceuticals Inc. (NYSE-M:NAVB) said late Monday that FDA issued a complete response letter for Lymphoseek tilmanocept for use in intraoperative...

Read the full 94 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >